Research
Longevity
NAD +
NAD – high-purity coenzyme for research into cellular energetics, DNA repair, and mitochondrial health.
Mix & match offer eligible
Research use only
Cellular Research
PT-141
Original price was: $70.00.$60.00Current price is: $60.00.
Commonly listed in research-supply catalogs for controlled laboratory work involving melanocortin receptor pharmacology, neurobehavioral models, analog comparison. This market positioning does not establish efficacy, safety, or an approved human use.
- Fast discreet 2 day shipping
- 3rd party tested
- 99% purity lab grade
Secure CheckoutAvailable payment: Credit Card, Apple Pay, Cash App, Venmo, Zelle, Bitcoin, Ethereum, USDT (Tether), USDC
Overview
PT-141, or bremelanotide, is a cyclic heptapeptide melanocortin receptor agonist related to melanotan II. Research interpretation should account for broad melanocortin receptor activity.
Evidence scope: Receptor, animal, and clinical pharmacology literature for the regulated drug substance. This TELOS record is a non-purchasable editorial draft for laboratory research use only and is not for human consumption.
Specification
| Property | Details |
|---|---|
| Reference ID | DRAFT-PT141 |
| Canonical Name | Bremelanotide (PT-141) |
| Research Classification | Cyclic melanocortin receptor agonist research peptide |
| Sequence Information | Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-OH |
| Molecular Formula | C50H68N14O10 |
| Molecular Weight | 1025.2 g/mol |
| Commercial Strength | Not assigned |
| Price | 0; commercial price not assigned |
| Inventory | 0; out of stock |
| Image | Not approved |
| Intended Use | Laboratory research use only (RUO) |
| Publication Status | Hidden draft pending TELOS commercial and editorial approval |
Potential Research Applications
Melanocortin receptor pharmacology
Receptor assays compare binding, signaling, and functional selectivity.
Neurobehavioral models
Preclinical research examines central melanocortin pathway responses.
Analog comparison
Studies can compare PT-141 with melanotan II and receptor-selective controls.
FAQ
What is PT-141?
PT-141, or bremelanotide, is a cyclic heptapeptide melanocortin receptor agonist related to melanotan II. Research interpretation should account for broad melanocortin receptor activity.
What evidence types are available?
Receptor, animal, and clinical pharmacology literature for the regulated drug substance.
Does the reference identity establish batch purity?
No. Molecular identity and literature references do not establish the purity, fill quantity, strength, or composition of a future TELOS lot. Batch-specific analytical documentation is required.
Why is this product not available to purchase?
This is a hidden editorial draft. TELOS has not assigned final commercial strength, price, inventory, imagery, or batch documentation.
How should this material be stored and handled?
Follow the future TELOS product label and batch documentation for the exact material form. Do not use handling instructions from another supplier.
Is this product intended for human consumption?
No. Any future TELOS listing will be for laboratory research use only and not for human consumption.
Continue exploring
Related compounds
Explore additional products from the live TELOS research catalog.
